相关实验视频

Updated: Jan 14, 2026

The Caco-2 Cell Bioassay for Measurement of Food Iron Bioavailability

The Caco-2 Cell Bioassay for Measurement of Food Iron Bioavailability

Published on: April 28, 2022

阿斯 (OGSG 2401) 研究协议:铁碳素糖用于胃肠道癌症中缺铁性贫血

Hiroki Yukami¹, Toshifumi Yamaguchi¹, Shunji Endo²

¹Cancer Chemotherapy Center, Osaka Medical and Pharmaceutical University, Daitō, Japan.

Future oncology (London, England)

|October 21, 2025

概括

铁炭酸马尔托 (FCM) 能够有效地控制在接受化疗的胃肠道癌症患者的缺铁性贫血. 这种治疗改善了血红蛋白水平,提高了癌症治疗期间的生活质量.

科学领域:

在瘤学瘤学.
血液学血液学血液学
胃肠病学胃肠病学

背景情况:

贫血是接受化疗的胃肠道癌症患者常见的并发症,对治疗的坚持和生活质量产生负面影响.
传统的贫血治疗方法,如输血和红色素形成刺激剂,具有显著的局限性,包括风险和供应问题.

研究的目的:

评价铁炭酸糖 (FCM) 对于治疗化学治疗的无法切除或复发的胃或结肠直肠癌患者的缺铁性贫血 (IDA) 的疗效和安全性.
评估FCM对该患者群体的血红蛋白水平和生活质量的影响.

主要方法:

一项前性多中心研究,涉及50名患有无法切除或复发的胃或结直肠癌和IDA的患者.
患者接受1500毫克的FCM,分为29天的3次500毫克剂量.
主要终点:8周后血红蛋白改善率. 二级终点:血红蛋白水平在4周和12周,以及生活质量评估在4,8周和12周.

主要成果:

这项研究旨在在8周内检测出33%的血红蛋白改善率.
二次结局措施包括4周和12周的血红蛋白变化和生活质量评估.

结论:

铁性碳酸 (FCM) 正在作为一种潜在的治疗方法来改善在接受化疗的胃肠道癌症患者的贫血.
预计这些发现将支持这种脆弱的患者群体的贫血管理策略.

关键词:

与癌症相关的与癌症有关的疾病.化学疗法化疗化疗结肠直肠癌是什么意思铁碳酸盐和铁碳酸盐和铁碳酸盐和铁碳酸盐.胃癌胃癌是一种胃癌.这是胃肠道癌症.静脉注射铁的使用方法缺铁性贫血是因为缺铁性贫血.

更多相关视频

Author Spotlight: Assessing the Impact of Novel Iron Chelators on Cancer Cell Metabolism

Author Spotlight: Assessing the Impact of Novel Iron Chelators on Cancer Cell Metabolism

Published on: February 23, 2024

Measurement of Tissue Non-Heme Iron Content using a Bathophenanthroline-Based Colorimetric Assay

Measurement of Tissue Non-Heme Iron Content using a Bathophenanthroline-Based Colorimetric Assay

Published on: January 31, 2022

相关概念视频

Serum Laboratory Studies, Stool Test, Breath Test

Serum Laboratory Studies, Stool Test, Breath Test

Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...